Dose standardisation of anticancer drugs

International Journal of Clinical Pharmacy

Volumn 33, Issue 2, 2011, Pages 221-228

  Pouliquen, Anne Lise ^a   Escalup, Laurence ^b   Jourdan, Nathalie ^a   Cottu, Paul ^b   Faure, Pierre ^a   Madelaine Chambrin, Isabelle ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT CURIE   (France)

Author keywords

Anticancer drugs; Dose calculation; Dose banding; Standardisation; Standardized rounded doses

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; DOCETAXEL; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED; RITUXIMAB; TRASTUZUMAB;

ARTICLE; BODY SIZE; CONTROLLED STUDY; DOSE CALCULATION; PRESCRIPTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; STANDARDIZATION;

ANTINEOPLASTIC AGENTS; BODY SURFACE AREA; CHEMISTRY, PHARMACEUTICAL; COST SAVINGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COSTS; DRUG DOSAGE CALCULATIONS; DRUG PACKAGING; DRUG THERAPY; FEASIBILITY STUDIES; FRANCE; HOSPITAL COSTS; HUMANS; MEDICAL WASTE; PHARMACY SERVICE, HOSPITAL; RETROSPECTIVE STUDIES;

EID: 79960182923     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9478-6     Document Type: Article

References (33)

1. DuBois D, DuBois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863-71.
2. Pinkel D. Cancer chemotherapy and body surface area. J Clin Oncol. 1998;16:3714-5. (Pubitemid 28506787)
3. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50:219-44.
4. Crawford JD, Terry ME, Rourke GM. Simplification of drug dosage calculation by application of the surface area principle. Pediatrics. 1950;5:783-90.
5. Wang Y, Moss J, Thisted R. Predictors of body surface area. J Clin Anesth. 1992;4:4-10.
6. Gurney H. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J Clin Oncol. 1996;14:2590-611. (Pubitemid 26300128)
7. Reilly JJ, Workman P. Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations. Cancer Chemother Pharmacol. 1993;32:411-8. (Pubitemid 23234656)
8. Newell DR. Getting the right dose in cancer chemotherapy-time to stop using surface area ? Br J Cancer. 2002;86:1207-8.
9. Markman M. 'Flat-fixed dosing' of chemotherapy: a concept whose time has come? Curr Oncol Rep. 2005;7:1-2. (Pubitemid 40277584)
10. Grochow LB, Baraldi C, Noe D. Is dose normalization to weight or body surface area useful in adults? J Natl Cancer Inst. 1990;82:323-5. (Pubitemid 20097710)
11. Felici A, Verweij J, Sparreboom A. Dosing strategies for anticancer drugs: the good, the bad and body-surface area. Eur J Cancer. 2002;38:1677-84.
12. Gurney H. I don't underdose my patients, do I? Lancet Oncol. 2005;6:637-8.
13. Plumridge RJ, Sewell GJ. Dose-banding of cytotoxic drugs: a new concept in cancer chemotherapy. Am J Health Syst Pharm. 2001;58:1760-4. (Pubitemid 32884870)
14. Loos WJ, de Jongh FE, Sparreboom A, et al. Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values. J Clin Oncol. 2006;24:1499-506. (Pubitemid 46638770)
15. Vigneron J. Stability studies of drugs used in oncology: the role of the hospital pharmacist. Eur J Hosp Pharm Pract. 2006;12:75-6.
16. de Lemos ML, Hamata L. Stability issues of parenteral chemotherapy drugs. J Oncol Pharm Pract. 2007;13:27-31. (Pubitemid 46894735)
17. Sawyer M, Ratain MJ. Body surface area as a determinant of pharmacokinetics and drug dosing. Invest New Drugs. 2001;19: 171-7. (Pubitemid 32423722)
18. Baker SD, Verweij J, Rowinsky EK, et al. Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001. J Natl Cancer Inst. 2002;94:1883-8.
19. Leveque D. Use of body weight and body surface area in dosing of anticancer agents in adult patients. Bull Cancer. 2007;94: 647-51. (Pubitemid 47413886)
20. Kaestner SA, Sewell GJ. Chemotherapy dosing part II: alternative approaches and future prospects. Clin Oncol (R Coll Radiol). 2007;19:99-107. (Pubitemid 46187486)
21. Baker JP, Jones SE. Rationalisation of chemotherapy services in the University Hospital Birmingham National Health Science Trust. J Oncol Pharm Practice. 1998;4:10-4.
22. Leach RH, Whitmarsh S, Partridge C, Potter SR. New cytotoxics production unit at University hospital, Birmingham. Hosp Pharm. 2000;7:109-10.
23. MacLean F, MacIntyre J, McDade J, Moyes D. Dose banding of chemotherapy in the Edinburgh Cancer Centre. Pharm J. 2003;270:691-3.
24. Leth-Miller D. Dose-banding of gemcitabine. Eur J Hosp Pharm Pract. 2007;2:52.
25. Hirte HW, Kagoma S, Zhong L, et al. Dose banding of chemotherapy doses at the Juravinski Cancer Centre. J Clin Oncol. 2006;24:6099. (abstract).
26. Kaestner S, Sewell G. Dose-banding of carboplatin: rationale and proposed banding scheme. J Oncol Pharm Pract. 2007;13:109-17. (Pubitemid 47399307)
27. Kaestner S, Sewell GJ. A National Survey Investigating UK Prescribers' Opinions on Chemotherapy Dosing and 'DoseBanding'. Clin Oncol (R Coll Radiol). 2009;21:320-8.
28. Bonnabry P, Cingria L, Ackermann M, Sadeghipour F, Bigler L, Mach N. Use of prospective risk analysis method to improve the safety of the cancer chemotherapy process. Int J Qual Health Care. 2005;18:9-16.
29. Chen CS, Seidel K, Armitage JO, et al. Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 1997;3:331-40. (Pubitemid 127530493)
30. Dooley MJ, Singh S, Michael M. Implications of dose rounding of chemotherapy to the nearest vial size. Support Care Cancer. 2004;12:653-6. (Pubitemid 39280316)
31. Kaestner S, Sewell G. Pharmacoeconomic aspects of dosebanding. Hosp Pharm Eur. 2006;26:33-4.
32. Kaestner S, Walker V, Roberts S, Perren T, Sewell G. Clinical and pharmacokinetic (pk) study on "dose-banded" and individual-dose chemotherapy: An interim report. J Oncol Pharm Practice. 2004;10:100.
33. Gillian A. British Oncology Pharmacy Association: www.bopawebsite.org. Toolkit: How to implement dose banding of chemotherapy. Accessed on 08/09/2008.